Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedMay 14, 2025
DataAggregated Company Financials
Companies65
  • 7D-0.4%
  • 3M-18.4%
  • 1Y-60.9%
  • YTD-26.9%

Last week, the Pharma industry hasn't moved much but Cronos Group is up 12% in that time. As for the longer term, the industry has declined 61% in the last year. Looking forward, earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 14 May 2025CA$10.2bCA$12.0b-CA$2,467,852,145.3019.8x-4.1x0.9x
Fri, 11 Apr 2025CA$8.9bCA$12.1b-CA$2,587,846,952.6317.6x-3.4x0.7x
Sun, 09 Mar 2025CA$11.1bCA$12.3b-CA$2,628,439,303.1622.6x-4.2x0.9x
Tue, 04 Feb 2025CA$12.0bCA$12.3b-CA$2,400,959,336.9225.9x-5x1x
Thu, 02 Jan 2025CA$13.0bCA$12.1b-CA$2,412,567,024.5931.2x-5.4x1.1x
Sat, 30 Nov 2024CA$14.4bCA$11.9b-CA$2,566,915,766.9021.1x-5.6x1.2x
Mon, 28 Oct 2024CA$20.5bCA$11.8b-CA$2,719,008,808.5818.4x-7.5x1.7x
Wed, 25 Sep 2024CA$18.2bCA$11.5b-CA$2,681,194,968.0922.3x-6.8x1.6x
Fri, 23 Aug 2024CA$19.1bCA$11.6b-CA$2,740,651,649.8422.1x-7x1.6x
Sun, 21 Jul 2024CA$19.9bCA$11.7b-CA$3,194,960,492.4519.1x-6.2x1.7x
Tue, 18 Jun 2024CA$19.3bCA$11.8b-CA$2,768,561,357.8613.2x-7x1.6x
Thu, 16 May 2024CA$25.1bCA$11.9b-CA$3,382,515,858.6214x-7.4x2.1x
Sat, 13 Apr 2024CA$25.1bCA$12.0b-CA$3,481,209,415.079x-7.2x2.1x
Mon, 11 Mar 2024CA$19.8bCA$11.9b-CA$3,898,781,168.647.5x-5.1x1.7x
Wed, 07 Feb 2024CA$24.6bCA$11.9b-CA$5,870,658,421.2413.4x-4.2x2.1x
Fri, 05 Jan 2024CA$18.7bCA$12.3b-CA$6,731,741,101.009.5x-2.8x1.5x
Sun, 03 Dec 2023CA$18.1bCA$12.4b-CA$6,759,446,881.008.7x-2.7x1.5x
Tue, 31 Oct 2023CA$14.5bCA$12.5b-CA$7,368,500,844.0011x-2x1.2x
Thu, 28 Sep 2023CA$20.2bCA$13.0b-CA$7,891,803,270.0013.8x-2.6x1.6x
Sat, 26 Aug 2023CA$13.8bCA$13.1b-CA$8,126,503,419.0014.7x-1.7x1.1x
Mon, 24 Jul 2023CA$14.9bCA$13.2b-CA$9,710,771,146.0012.2x-1.5x1.1x
Wed, 21 Jun 2023CA$14.7bCA$13.2b-CA$9,399,141,476.0012.5x-1.6x1.1x
Fri, 19 May 2023CA$15.2bCA$13.3b-CA$10,459,039,713.0010x-1.5x1.1x
Sun, 16 Apr 2023CA$15.1bCA$13.2b-CA$9,929,654,529.0010x-1.5x1.1x
Tue, 14 Mar 2023CA$18.6bCA$13.8b-CA$10,605,914,094.009.1x-1.8x1.3x
Thu, 09 Feb 2023CA$20.0bCA$13.6b-CA$10,158,913,165.0010x-2x1.5x
Sat, 07 Jan 2023CA$20.4bCA$13.5b-CA$10,111,258,139.0013.4x-2x1.5x
Mon, 05 Dec 2022CA$33.4bCA$13.6b-CA$10,188,493,690.0016.8x-3.3x2.5x
Wed, 02 Nov 2022CA$28.2bCA$13.4b-CA$9,386,086,629.0011.4x-3x2.1x
Fri, 30 Sep 2022CA$24.6bCA$13.5b-CA$9,398,391,382.0011.1x-2.6x1.8x
Sun, 28 Aug 2022CA$32.2bCA$13.0b-CA$8,971,135,456.0012.8x-3.6x2.5x
Tue, 26 Jul 2022CA$29.5bCA$12.2b-CA$5,865,843,259.0011.4x-5x2.4x
Thu, 23 Jun 2022CA$27.0bCA$12.2b-CA$5,798,964,209.008.2x-4.7x2.2x
Sat, 21 May 2022CA$33.7bCA$12.1b-CA$5,659,714,969.0010.3x-5.9x2.8x
Price to Earnings Ratio

-5.9x


Total Market Cap: CA$33.7bTotal Earnings: -CA$5,659,714,969.00Total Revenue: CA$12.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -4x202320242025
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 0.85x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market2.30%
Healthcare0.92%
Pharma-0.41%
Pharma-0.41%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRON Cronos GroupCA$2.8312.3%
+CA$118.6m		-29.6%PE15.7x
ACB Aurora CannabisCA$7.1712.9%
+CA$45.0m		-25.0%PE22.1x
TRUL Trulieve CannabisCA$6.343.4%
+CA$40.1m		-60.6%PS0.7x
WEED Canopy GrowthCA$2.0113.6%
+CA$38.0m		-84.9%PS1.1x
VREO Vireo GrowthCA$0.5915.7%
+CA$29.4m		-21.3%PS1.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HLS

CA$4.68

HLS Therapeutics

7D

7.6%

1Y

18.5%

VREO

CA$0.59

Vireo Growth

7D

15.7%

1Y

-21.3%

MTLC

CA$0.42

MTL Cannabis

7D

42.4%

1Y

95.3%

GUD

CA$5.81

Knight Therapeutics

7D

-4.6%

1Y

-5.5%

author-image

Paladin Acquisition And New Launches Will Expand Market Presence

May 10 Acquisitions and expanded partnerships bolster Knight's Canadian and oncology revenue, enhancing stability and growth prospects.

VRNO

CA$1.01

Verano Holdings

7D

-9.8%

1Y

-86.7%

CPH

CA$12.78

Cipher Pharmaceuticals

7D

-11.3%

1Y

47.1%

GTII

CA$7.70

Green Thumb Industries

7D

-7.3%

1Y

-56.4%

CRON

CA$2.83

Cronos Group

7D

12.3%

1Y

-29.6%

TRUL

CA$6.34

Trulieve Cannabis

7D

3.4%

1Y

-60.6%

WEED

CA$2.01

Canopy Growth

7D

13.6%

1Y

-84.9%

AYR.A

CA$0.37

Ayr Wellness

7D

-14.9%

1Y

-89.3%

OGI

CA$1.72

Organigram Global

7D

13.9%

1Y

-30.6%

GRIN

CA$0.60

Grown Rogue International

7D

-6.3%

1Y

-37.5%

CL

CA$1.00

Cresco Labs

7D

-15.3%

1Y

-64.3%

Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up

May 01
Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up

HITI

CA$3.19

High Tide

7D

-2.4%

1Y

1.6%

author-image

Expanding German Medical Cannabis And Cabana Club Will Build Opportunities

Apr 27 Strategic expansion in the German market and leveraging Canadian connections may boost future revenue.

ACB

CA$7.17

Aurora Cannabis

7D

12.9%

1Y

-25.0%

author-image

EU GMP And TGA Expertise Will Expand Global Cannabis Reach

Apr 26 Strategic international expansion and regulatory changes in key markets could significantly boost future revenues and medical cannabis margins.